Comprehensive investigation of AAV tropism across human iPSC-derived neuronal subtypes
Preprint
Abstract
Recombinant Adeno-associated viruses (AAVs) are widely used for gene delivery in the central nervous system and have become central tools in both gene therapy and basic neuroscience research. However, although AAV serotypes have been extensively characterized in rodent models, their performance in human neurons, particularly those derived from induced pluripotent stem cells (iPSCs), remains poorly characterized. While human iPSC-derived neurons are increasingly used for disease modeling and drug screening, their susceptibility to viral transduction varies and remains difficult to predict. In this study, we systematically evaluated the transduction efficiency and toxicity profiles of 18 wild-type and engineered AAV serotypes across three distinct types of iPSC-derived neurons, relevant to disease modeling and drug discovery: cortical projection neurons, NGN2- induced forebrain-like neurons, and dopaminergic neurons and four doses (1E3, 1E4, 1E5 and 2E5 genome copies per cell). Using automated high-throughput confocal imaging and quantification of reporter gene expression, we identified several serotypes with robust and efficient transduction across all neuronal subtypes. Among these, three serotypes AAV6, AAV6.2 and AAV2.7m8 showed consistently high performance. To assess safety, we quantified cell number and neurite morphology, finding that while high transduction and gene expression correlate with toxicity, sensitivity varied across neuronal subtypes, with NGN2 neurons being most vulnerable and dopaminergic neurons most resilient. Finally, we validated our findings in a more complex 3D model by testing one of the best-performing serotypes, AAV2.7m8, in both whole and dissociated human cerebellar organoids. Together, our results establish a benchmark dataset for AAV performance in human iPSC- derived neurons and provide practical guidance for AAV based gene delivery in human in vitro neural models. This resource will be valuable for both basic research and preclinical applications aiming to manipulate gene expression in human neurons and understanding AAV tropism in disease-relevant cell types.Keywords
Funding Information
- DZNE Stiftung
This publication has 33 references indexed in Scilit:
- A comprehensive study of AAV tropism across C57BL/6 mice, BALB/c mice, and crab-eating macaquesMolecular Therapy - Methods & Clinical Development, 2025
- Unlocking the potential of adeno-associated virus in neuroscience: a brief reviewMolecular Biology Reports, 2024
- Two engineered AAV capsid variants for efficient transduction of human cortical neurons directly converted from iPSCJournal of Neuroscience Methods, 2021
- Transcriptome profiling of human pluripotent stem cell‐derived cerebellar organoids reveals faster commitment under dynamic conditionsBiotechnology and Bioengineering, 2021
- Adeno-Associated Viral Vectors in Neuroscience ResearchMolecular Therapy - Methods & Clinical Development, 2020
- Adeno-Associated Virus (AAV) as a Vector for Gene TherapyBioDrugs, 2017
- A Designer AAV Variant Permits Efficient Retrograde Access to Projection NeuronsNeuron, 2016
- Self-Organization of Polarized Cerebellar Tissue in 3D Culture of Human Pluripotent Stem CellsCell Reports, 2015
- Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem CellsNeuron, 2013
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007